Metoclopramide is a substituted benzamide.

It is chemically related to procainamide but has no pharmacological similarity to it.

It is mainly used as an antiemetic and prokinetic agent in the G I T.

Mechanism of action.

  • High doses block dopamine and serotonin receptors in the chemoreceptor trigger zone of the CNS.
  • This leads to increased sensitization of tissues to acetylcholine,
  • upper GI motility without secretions, and lower esophageal sphincter tone.

Clinical uses.

  • Antiemetic: Used in different types of vomiting, including; postoperative, drug-induced, a disease associated(especially migraine), radiation sickness, but is less effective in motion sickness.
  • Dyspepsia and other functional g.i.t disorders, including persistent hiccups.
  • Gastroesophageal reflux disease (GERD): the drug does not require aid in the healing of esophagitis but may be used as an adjuvant to acid suppression.
  • Gastrokinetic: To accelerate gastric emptying:

(a) When emergency general anesthesia has to be administered, and the patient has taken food less than 4 hours before.

(b) To relieve postvagotomy or diabetic gastroparesis associated gastric stasis.

(c) To facilitate duodenal intubation.

Drug interaction.

  • The bioavailability of cimetidine is also reduced.
  • Abolishes the therapeutic effect of levodopa by blocking dopamine receptors in basal ganglia.
  • It hastens the absorption of drugs, e.g., aspirin and diazepam, by facilitating gastric emptying.
  • The extent of absorption of digoxin is reduced.

Adverse effects.

  • Peri-orbital edema, skin rash, and galactorrhea.
  • Sedation, dizziness, loose stools, muscle dystonias
  • Long-term use can cause parkinsonism and gynecomastia.

Contraindication.

  • Phaeochromocytoma: may cause a hypertensive crisis.
  • Epilepsy
  • The drug should not be used to augment lactation. The amount secreted in milk is small, but suckling infants may develop loose motions, dystonia, and myoclonus.

Dosage.

  • 10 mg (children 0.2–0.5 mg/kg) TDS oral or i.m.
  • For CINV 0.3–2 mg/kg slow i.v./i.m.
  • PERINORM, MAXERON, REGLAN, SIGMET, 10 mg tablets; 5mg/5 ml syrup; 10 mg/2 ml inj.; 50 mg/10 ml injection.

Leave a Reply

Your email address will not be published. Required fields are marked *